NCT07484399Not yet recruiting
Comparing Effects of HIIT and MICT on Functional Mobility, Muscle Strength, and Quality of Life in Diabetic Patients
Comparing The Effects of High Intensity Interval Training and Moderate Intensity Continuous Training on Functional Mobility, Muscle Strength, and Quality of Life in Diabetic Patients
Source: ClinicalTrials.gov · Last updated 20 Mar 2026
Brief summary (registry, in English)
To compare the effects of High-Intensity Interval Training (HIIT) and Moderate-Intensity Continuous Training (MICT) on functional mobility, muscle strength, and quality of life in individuals with type-2-diabetes.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 28 (estimated)
- First submitted
- 16 Mar 2026
- Start date
- 5 Mar 2026
- Primary completion date
- 17 Jul 2026
- Lead sponsor
- Riphah International University
- Diseases
- Type 2 diabetes
- NCT number
- NCT07484399
What you commit to
- Study type: Interventional
- Planned participants: 28
- From 5 Mar 2026 to the primary completion date, 17 Jul 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- • Individuals with significant orthopedic limitations.
- Individuals with uncontrolled cardiovascular disease or musculoskeletal issues.
- Individuals with incontinence issues during physical activity or inability to comply to study protocols
Who the study is looking for
- :• Adults aging form 35 to 65.
- Both male and female diabetic patients.
- Individuals diagnosed with type 2 diabetes for at least five years.
- Individuals able to participate in moderate to intense physical activity.
Age in the registry: 35 years to 65 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.